# Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease

> **NCT01133860** · PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 12 (actual)

## Conditions studied

- Blood Platelet Disorders

## Interventions

- **DRUG:** eltrombopag

## Key facts

- **NCT ID:** NCT01133860
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-07-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01133860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01133860, "Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01133860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*